Roche Shares Update on the Investigation of Satralizumab for Bone Health and the SHIELD DMD Study

February 20, 2026

On February 20, 2026, Roche shared an important update in a community letter regarding their work in bone health in Duchenne and the SHIELD DMD study.

Read more by visiting their community letter here.